ST

Silence Therapeutics

Organization

Heard in 4 episodes across 4 shows since Oct 2026

Silence Therapeutics plc is a clinical-stage biotechnology company developing precision-engineered medicines based on RNA interference (RNAi), particularly short interfering RNA (siRNA) therapeutics. Its pipeline targets diseases with significant unmet medical need, including hematologic and cardiometabolic conditions, using its proprietary delivery and gene-silencing technologies.

Discussed inMarkets100%

Episodes

4
across 4 shows

This week

0
episodes on 0 shows

Expert statements

2
2 positive

Share of the conversation

Mentions of Silence Therapeutics per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 15Sep 6Sep 29Oct 21Nov 12
Show the data
DayShare (7-day)Mentions
Oct 190.01‰1
Oct 200.03‰2
Oct 230.04‰2
Oct 260.04‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Silence Therapeutics comes up on a podcast

One email a week at most, with the new episodes that mention Silence Therapeutics. Free, no account needed, unsubscribe in one click.

What experts have said about Silence Therapeutics

2 statements · 2 positive

  1. Matthew CloutierPositiveOct 26, 2026· Breaking Biotech

    The Silent Therapeutics acquisition was valued at about $1.3 billion.

    “the deal was for about $1.3 billion”

    Listen at 3:33

    Open the episode · 120 - Breaking Biotech Week End Wrap Up - Oct 25th, 2026
  2. Ali MortazaviPositiveOct 23, 2026· Biotech Hangout

    Silence’s switch to polycythemia vera was an exceptionally good corporate decision.

    “someone in silence, i don't know who, decided to switch to PV. And honestly, that's probably one of the best, best biotech corporate decisions ever made.”

    Listen at 34:07

    Open the episode · Episode 200 - October 23, 2026

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

4 episodes featuring Silence Therapeutics, newest first